miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun

Hypertrophic cardiomyopathy (HCM) is a serious monogenic disease characterized by cardiac hypertrophy, fibrosis, sudden cardiac death, and heart failure. Previously, we identified that miR-139-5p was down-regulated in HCM patients. However, the regulatory effects of miR-139-5p remain unclear. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ming, Su, Shui-yun, Wang, Wei, Qiu, Jian-hui, Li, Ru-tai, Hui, Lei, Song, Mei, Jia, Hui, Wang, Ji-zheng, Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843750/
https://www.ncbi.nlm.nih.gov/pubmed/29440459
http://dx.doi.org/10.1042/BSR20171430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843750/
https://www.ncbi.nlm.nih.gov/pubmed/29440459
http://dx.doi.org/10.1042/BSR20171430

Ejemplares similares